Camurus AB | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK6.28 |
Market Cap |
SEK3.53 B |
Shares Outstanding |
47.98 M |
Public Float |
15.74 M |
Address |
Ideon Science Park Lund SN 223 70 Sweden |
Employees | - |
Website | http://www.camurus.com |
Updated | 07/08/2019 |
Camurus AB engages in the research, development, and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer, and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden. |